key: cord-0813210-krfaemsn
authors: Dudreuilh, Caroline; Moutzouris, Dimitrios-Anestis
title: Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?
date: 2020-06-27
journal: Am J Kidney Dis
DOI: 10.1053/j.ajkd.2020.06.006
sha: 325e6a047cd76330eb9e6683654f47ae0ac9bf4d
doc_id: 813210
cord_uid: krfaemsn

nan

1

To the Editor:

While dialysis patients are known to have impaired antibody responses to pathogens and fluctuation of antibody levels (1), the response to coronavirus disease 2019 in this population remains to be determined. De Vriese et al (2) present the first evaluation of potential antibody responses in a dialysis population. We agree that two sequential negative COVID-19 swabs before de-isolating dialysis patients is a reasonable approach, as we recently demonstrated (3). De Vriese et al studied the presence of IgG against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) protein in 7 patients and concluded that patients develop an antibody response within 15 days. While we acknowledge that these findings are novel, we would like to highlight that they might not be applicable to other dialysis populations with COVID-19: first, the infection rate in their population was very low (7/289 [2.5%]) and most of these patients had a severe form of the disease (3 [43%] died and one was still in the intensive care unit [ICU]). In comparison, in our experience (4) 11.3% of our haemodialysis population had COVID-19, and only 7 of 76 died (9.2%). IgG against SARS-Cov2 N protein has been shown to be higher in ICU compared to non-ICU patients (5) . Therefore, it remains to be elucidated if those results are applicable to any hemodialysis population, and if assessing in combination with anti-spike (S) protein IgG has a prognostic role (5) . Moreover, it remains to be confirmed how long these antibodies will last and their clinical relevance in larger populations. 

IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis

Deisolation of COVID-19-positive hemodialysis patients in the outpatient setting: a singlecenter experience

Delivering Dialysis During the COVID-19 Outbreak: Strategies and Outcomes

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients

Financial Disclosure: The authors declare that they have no relevant financial interests.Peer Review: Received June 10, 2020. Accepted June 13, 2020 after editorial review by a Deputy Editor.